NCT03910387 2025-12-16
Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer
Emory University
Phase 2 Completed
Clinical Trials
5 trialsNCT03453489 2025-04-10
AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT03223428 2024-07-24
RELAX
TerSera Therapeutics LLC
Completed
NCT04543955 2023-06-27
Telotristat With Lutathera in Neuroendocrine Tumors
University of Kentucky
Phase 2 Terminated
NCT03790111 2023-04-19
TELE-ABC
TerSera Therapeutics LLC
Phase 2 Terminated